dimyristoylphosphatidylcholine has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anantha, M; Bally, MB; Chen, KTJ; Chow, N; Dai, Z; Heroux, D; Leung, AWY; Nosrati, Z; Ryan, GM; Wang, L; Wretham, N | 1 |
1 other study(ies) available for dimyristoylphosphatidylcholine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.
Topics: Animals; Benzothiazoles; Copper; Dimyristoylphosphatidylcholine; Leukemia, Myeloid, Acute; Liposomes; Mice; Naphthyridines | 2022 |